Skip to main content

Table 6 Economic impact of HIV and HIV/HCV populations with one comorbidity

From: Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice

  HIV+ mono-infected patients HIV/HCV
co-infected patients
Delta between HIV/HCV and HIV+ patients [%] p-value
Mean total cost € 9,566.95 € 17,426.32 45.10% < 0.001
Mean total cost without HCV therapy cost € 9,566.95 € 11,159.68 14.27% 0.001
Mean total cost without hospitalization/DH events cost € 8,759.71 € 17,425.76 49.73% < 0.001
Mean total cost without HCV therapy cost and hospitalization/DH events cost € 8,759.71 € 11,159.12 21.50% < 0.001
Mean HIV therapy cost € 7,117.33 € 9845.34 27.71% < 0.001
Mean laboratory tests cost € 880.19 € 468.45 −87.89% 0.001
Mean diagnostic and specialist procedures cost € 452.52 € 204.58 − 121.20% < 0.001
Mean drug cost € 309.68 € 640.74 51.67% < 0.001